Evidence map›Paper›PMID 32508659›Full record

ArticleFrontiers in pharmacology2020

Inhibition of K

Jonas Goldin Diness, Lea Abildgaard, Sofia Hammami Bomholtz, Mark Alexander Skarsfeldt, Nils Edvardsson, Ulrik S Sørensen, Morten Grunnet, Bo Hjorth Bentzen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Review
  2. NaInternational journal of cardiology. Heart & vasculature · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jonas Goldin DinessAcesion Pharma, Copenhagen, Denmark.
Lea AbildgaardAcesion Pharma, Copenhagen, Denmark.
Sofia Hammami BomholtzAcesion Pharma, Copenhagen, Denmark.
Mark Alexander SkarsfeldtAcesion Pharma, Copenhagen, Denmark.
Nils EdvardssonAcesion Pharma, Copenhagen, Denmark.
Ulrik S SørensenAcesion Pharma, Copenhagen, Denmark.
Morten GrunnetAcesion Pharma, Copenhagen, Denmark.
Bo Hjorth BentzenAcesion Pharma, Copenhagen, Denmark.
Acesion Pharma (Denmark) · DKUniversity of Gothenburg · SE

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundHypokalemia reduces the cardiac repolarization reserve. This prolongs the QT-interval and increases the risk of ventricular arrhythmia; a risk that is exacerbated by administration of classical class 3 anti-arrhythmic agents.Small conductance Ca PURPOSE: To study the effects of pharmacological K

methodsThe current at +10 mV was compared in HEK293 cells stably expressing K

resultsHypokalemia slightly increased K

conclusionHypokalemia was associated with an increased incidence of VF, an effect that also seen in the presence of dofetilide. In comparison, the structurally and functionally different K

Indexed as

antiarrhythmic drugarrhythmiadofetilidehypokalemiaKCa2 channel inhibitorKv11.1 blockersSK channelSK channel inhibitor

Identifiers

PMID32508659
PMCPMC7251152
OpenAlexW3033579662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.